Cynthia Patton is taking the legal reins of a company developing gene-writing technology that's led by a former AbbVie president.
April 18, 2023 at 12:37 PM
2 minute read
Tessera Therapeutics, a Boston-area startup attempting to revolutionize the technology used to edit DNA and RNA, has hired Cynthia Patton, a 20-year veteran of law in the biotech space, as general counsel and secretary.
The company, founded just five years ago, already has attracted more than $532 million in funding, drawn by its technology and the pedigree of its leadership team, including CEO Michael Severino, a former vice chairman and president of AbbVie.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
Credit: Paulista/Adobe Stock
